MOONLAKE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.91 USD | +2.25% |
|
-1.92% | -33.91% |
| May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
| May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Bio Therapeutic Drugs | +2.25% | -1.92% | -33.91% | +47.32% | - | 2.51B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- MLTX Stock
- Charts MoonLake Immunotherapeutics
- Comparison Chart
